Children will get corona vaccine: Trial of covacin will start in two weeks, 525 children aged 2 to 18 will be vaccinated
The third wave of Corona is good news amid fears of becoming too dangerous for children. The government has approved a trial of vaccinations on children. Dr VK Pol, a member of the policy commission, said in a statement on Tuesday that the Drug Controller General of India (DFGI) had approved the second and third phase clinical trials of covacin on children aged 2 to 18 years.
also read
Dr. Paul said that the trial will start in the next 10-12 days. In addition, the anti-covid drug 2DG, developed by DRDO, has also been approved for emergency use. We will examine the drug to integrate it into the treatment protocol. Covacin is currently being used for 18+ vaccinations in the country.
If PM Kisan's installment has not come in your account, immediately complain to this number, it will be resolved soon.
Dr. Paul said that the trial will start in the next 10-12 days. In addition, the anti-covid drug 2DG, developed by DRDO, has also been approved for emergency use. We will examine the drug to integrate it into the treatment protocol. Covacin is currently being used for 18+ vaccinations in the country.
ALSO RAED
Trials to be held in Delhi, Patna and Nagpur The
Subject Experts Committee has agreed to conduct trials on 525 children in AIIMS Delhi, AIIMS Patna and the Institute of Medical Sciences, Nagpur. If this is successful, then after Canada and the United States, the indigenous corona vaccine will also be available in India for the age group of 2 to 18 years. Bharat Biotech has developed covacin in collaboration with ICMR.
Data Monitoring Board to provide data for second phase trial
According to sources, the committee of experts has directed the Data and Safety Monitoring Board (DSMB) to make available the second phase security data before getting approval from CDSCO for the company's third phase trial. The proposal was earlier considered at a meeting on February 24 and Bharat Biotech was directed to introduce a revised clinical trial protocol.
The design of the upcoming Google Pixel will be hut or, triple rear camera will get horizontal; Find out the specifications of the phone
Trials to be held in Delhi, Patna and Nagpur The
Subject Experts Committee has agreed to conduct trials on 525 children in AIIMS Delhi, AIIMS Patna and the Institute of Medical Sciences, Nagpur. If this is successful, then after Canada and the United States, the indigenous corona vaccine will also be available in India for the age group of 2 to 18 years. Bharat Biotech has developed covacin in collaboration with ICMR.
Data Monitoring Board to provide data for second phase trial
According to sources, the committee of experts has directed the Data and Safety Monitoring Board (DSMB) to make available the second phase security data before getting approval from CDSCO for the company's third phase trial. The proposal was earlier considered at a meeting on February 24 and Bharat Biotech was directed to introduce a revised clinical trial protocol.
ALSO READ
The US Food and Drug Administration (US-FDA) on Monday approved the Pfizer-BioNTecch corona vaccine for 12- to 15-year-olds. Until now, the vaccine was given to people over the age of 16.
Canada has previously approved this first vaccine for children. It is the first country in the world to do so. Vaccination of children between the ages of 12 and 15 is believed to have paved the way for the opening of a large number of schools and summer camps in the United States.
Video collection of destruction created by Tawakte Vavajoda in Gujarat
The US Food and Drug Administration (US-FDA) on Monday approved the Pfizer-BioNTecch corona vaccine for 12- to 15-year-olds. Until now, the vaccine was given to people over the age of 16.
Canada has previously approved this first vaccine for children. It is the first country in the world to do so. Vaccination of children between the ages of 12 and 15 is believed to have paved the way for the opening of a large number of schools and summer camps in the United States.
No comments:
Post a Comment